The Melanoma Research Foundation is committed to advancing research across the spectrum of melanoma鈥攆rom prevention through diagnosis, staging, treatment, and survivorship.

To that end, the foundation has issued its 2023 request for proposals. Awards to be offered in 2023 include: 

CURE OM Options Bring Hope Award in honor of Lindsay Zubeck (CURE OM): Will provide funding of up to $250,000 over two years ($150,000 for year one and $100,000 for year two) to an investigative team whose research will advance treatment for HLA-A*02:01-negative patients with unresectable or metastatic uveal melanoma. Teams should consist of a PI and at least one co-PI, ideally from different institutions. Teams consisting of both basic scientists and clinicians are encouraged, as is the inclusion of a junior scientist.

Established Investigator Awards (EIA): Will provide funding of up to $100,000 per year for two years to established melanoma researchers or senior researchers working in closely related fields who wish to move into melanoma research.

Career Development Awards (CDA): Will provide funding of up to $50,000 per year for two years to junior investigators. Researchers who are beginning a research career focused on melanoma are eligible. This year, in addition to general CDAs, the MRF will again offer the Silverstein Family Research Grant Challenge Women in Science Award/WIS CDA.

The following categories are the identified unmet needs in melanoma research selected as specific topic proposals for 2023: prevention, early detection, and population science; tumor cell dormancy and metastasis; therapy and resistance; and rare melanoma tumors.

To be eligible, applicants must hold a PhD or MD degree or equivalent at the time of submission. For this RFP, applicants may be the PI or co-PI on only one submitted application.

For complete program guidelines and application instructions, see the Melanoma Research Foundation website.